Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ferraris Group was a leading medical technology company specializing in the development and manufacture of respiratory diagnostic and monitoring equipment. The company was most famous for its "Wright" brand of peak flow meters, which became a global standard for asthma management. Its product portfolio included advanced pulmonary function testing systems, cardiac monitoring devices, and specialized medical engineering components. Headquartered in the United Kingdom, the group operated through several subsidiaries including Ferraris Respiratory and Reynolds Medical. In 2007, the company was acquired by Viasys Healthcare for approximately $80 million to bolster its respiratory care division. Following subsequent industry consolidations, the legacy of Ferraris Group's technology now resides within Becton Dickinson (BD).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ferraris Group.